KLRA Kailera Therapeutics, Inc.
Company Analysis
Latest News
🟢 Kailera Therapeutics, Inc. extends move to 5.5% up
KLRA is trading at $20.99, up 5.5% versus the comparison close of $19.90 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Kailera Therapeutics, Inc. is trading 6.3% up today, extending its multi-day momentum with no clear catalyst
Kailera Therapeutics, Inc. is trading at $21.15 (6.3%) up in pre-market, extending its recent multi-day uptrend despite a lack of fresh company-specific news...
🟢 Kailera Therapeutics, Inc. extends move to 5.3% up
KLRA is trading at $20.14, up 5.3% versus the comparison close of $19.13 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Kailera Therapeutics, Inc. is trading 4.6% up today, extending a rebound from its June 16 decline
Kailera Therapeutics, Inc. is trading at $20.02, up 4.6%, extending a rebound that started after its June 16 decline. • Recent news and filings show no fresh...
🟢 Kailera Therapeutics, Inc. is trading 5.1% up today as shares rebound from recent losses
Kailera Therapeutics, Inc. is trading 5.1% up at $19.50 as the stock appears to be rebounding from a 5.7% drop on June 16. • The move comes despite a lack of...
🔴 Kailera Therapeutics, Inc. extends move to 5.5% down
KLRA is trading at $18.58, down 5.5% versus the comparison close of $19.67 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 Kailera Therapeutics, Inc. is trading 4.5% down today on apparent profit-taking
Kailera Therapeutics, Inc. is trading 4.5% down at $18.79 today on apparent profit-taking following recent post-IPO strength. • There are no fresh...
🟢 Kailera Therapeutics, Inc. extends move to 5.7% up
KLRA is trading at $19.96, up 5.7% versus the comparison close of $18.89 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Kailera Therapeutics, Inc. is trading 1.9% up today amid a broader biotech rally and post-IPO price discovery
Kailera Therapeutics, Inc. is trading at $19.24 (up 1.9%) as the stock recovers from recent post-IPO volatility amid a broader rally in the biotechnology...